Venus Remedies has received approval in Argentina for its antibiotic Ceftriaxone. This marks a significant step in the company's Latin America expansion. Argentina is a key market for critical care therapies. Ceftriaxone is vital for treating serious bacterial infections. This authorization strengthens Venus Remedies' global presence and commitment to accessible anti-infective treatments.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/x1SmKLv
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Venus Remedies expands Latin America presence with Argentina nod for antibiotic






0 comments:
Post a Comment